Björn Walse (Former)
1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Identification of an osteopontin-derived peptide that binds neuropilin-1 and activates vascular repair responses and angiogenesis
(
- Contribution to journal › Article
- 2023
-
Mark
Targeting Toll-like receptor-driven systemic inflammation by engineering an innate structural fold into drugs
(
- Contribution to journal › Article
- 2022
-
Mark
The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity
(
- Contribution to journal › Article
- 2021
-
Mark
Benzimidazole–galactosides bind selectively to the Galectin-8 N-Terminal domain : Structure-based design and optimisation
(
- Contribution to journal › Article
-
Mark
Going to extremes - a metagenomic journey into the dark matter of life
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Insight into the dimer dissociation process of the Chromobacterium violaceum (S)-selective amine transaminase
(
- Contribution to journal › Article
- 2018
-
Mark
Collagen VI contains multiple host defense peptides with potent in vivo activity
(
- Contribution to journal › Article
-
Mark
Transaminase-Catalyzed Racemization with Potential for Dynamic Kinetic Resolutions
(
- Contribution to journal › Article
- 2017
-
Mark
Intact Protein Analysis at 21 Tesla and X-Ray Crystallography Define Structural Differences in Single Amino Acid Variants of Human Mitochondrial Branched-Chain Amino Acid Aminotransferase 2 (BCAT2)
(
- Contribution to journal › Article
- 2016
-
Mark
Cancer differentiating agent hexamethylene bisacetamide inhibits BET bromodomain proteins
(
- Contribution to journal › Article